Table 3 Treatment modalities and complications
From: Interventional bronchoscopy in malignant central airway obstruction by extra-pulmonary malignancy
Variables | N = 98 |
|---|---|
Time interval from diagnosis of MCAO to intervention, months | 0.4 (0.2 – 1.0) |
Treatment modalities | |
 Mechanical debulking | 83 (84.7) |
 Silicone stent | 69 (70.4) |
  Tube stent | 65 (66.3) |
  Y stent | 7 (7.1) |
 Laser | 37 (37.8) |
 Tracheostomy | 4 (4.1) |
Number of interventional bronchoscopies | |
 1 | 63 (64.3) |
  ≥ 2 | 35 (35.7) |
Technical failure | 10 (10.2) |
MCAO as initial diagnosis of malignancy | 22 (22.4) |
 No adjuvant treatment after interventional bronchoscopy | 7 (7.1) |
 Adjuvant radiation therapy | 10 (10.2) |
 Adjuvant chemotherapy | 6 (6.1) |
 Adjuvant surgical resection | 2 (2.0) |
MCAO as disease progression of malignancy | 76 (77.6) |
 No adjuvant treatment after interventional bronchoscopy | 35 (35.7) |
 Adjuvant radiation therapy | 28 (28.6) |
 Adjuvant chemotherapy | 18 (18.4) |
 Adjuvant surgical resection | 1 (1.0) |
Acute complications | 20 (20.4) |
 Respiratory distress | 13 (13.3) |
 Excessive bleeding | 10 (10.2) |
 Pneumothorax | 3 (3.1) |
 Procedure-related deatha | 3 (3.1) |
30-day mortality | 13 (13.3) |
Chronic complications | 25 (25.5) |
 Mucostasis | 19 (19.4) |
 Granulation tissue overgrowth | 10 (10.2) |
 Stent migration | 6 (6.1) |